Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBITDA Margin: 2010-2012

Historic EBITDA Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -54.46%.

  • Sonoma Pharmaceuticals' EBITDA Margin rose 3995.00% to -54.46% in Q4 2012 from the same period last year, while for Dec 2012 it was -30.14%, marking a year-over-year increase of 3099.00%. This contributed to the annual value of -58.70% for FY2012, which is 2189.00% up from last year.
  • According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' EBITDA Margin is -54.46%, which was down 76.07% from -30.93% recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year EBITDA Margin high stood at 8.02% for Q2 2012, and its period low was -109.41% during Q2 2010.
  • In the last 3 years, Sonoma Pharmaceuticals' EBITDA Margin had a median value of -59.39% in 2011 and averaged -59.06%.
  • Data for Sonoma Pharmaceuticals' EBITDA Margin shows a peak YoY increase of 8,088bps (in 2012) and a maximum YoY decrease of 328bps (in 2012) over the last 5 years.
  • Quarterly analysis of 3 years shows Sonoma Pharmaceuticals' EBITDA Margin stood at -97.28% in 2010, then skyrocketed by 287bps to -94.41% in 2011, then soared by 3,995bps to -54.46% in 2012.
  • Its EBITDA Margin was -54.46% in Q4 2012, compared to -30.93% in Q3 2012 and 8.02% in Q2 2012.